Cantor Fitzgerald Comments on Cytokinetics FY2025 Earnings
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Cytokinetics in a research note issued to investors on Tuesday, May 13th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will post earnings of ($5.21) per share for the year. Cantor Fitzgerald currently has a “Strong-Buy” […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Cytokinetics in a research note issued to investors on Tuesday, May 13th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will post earnings of ($5.21) per share for the year. Cantor Fitzgerald currently has a “Strong-Buy” […]
